Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Qinglong Hi-tech Co., Ltd. is a Chinese biotechnology and pharmaceutical company specializing in the research, development, and large-scale production of natural plant extracts. The company is recognized as a leading global supplier of standardized Ginkgo biloba extract (GBE) and related pharmaceutical preparations. Their product portfolio includes Ginkgo leaf tablets, capsules, and various health supplements aimed at treating cardiovascular and cerebrovascular conditions. Qinglong Hi-tech operates GMP-certified manufacturing facilities and integrates cultivation, extraction, and finished product manufacturing. The company serves both the domestic Chinese market and international pharmaceutical and nutraceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinglong Hi-tech.